Pfizer and BioNTech sought first COVID-19 vaccine approval in the United States. Pharmaceuticals companies Pfizer and BioNTech on Friday had sought an approval to release their jointly-developed COVID-19 vaccine early in the United States as a first step towards relief. This, as the increasing number of coronavirus infections prompted a return to shutdowns that traumatized … Read more
Pfizer had ended its clinical trials for COVID-19 vaccine with 95% efficacy. Pfizer Inc. on Wednesday said that the final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective Also, Pfizer said that it had the required two months of safety data and will apply for an emergency use authorization … Read more
Pfizer was “very close” to applying for an emergency use approval, according to the company’s CEO Pfizer’s CEO on Tuesday said that Pfizer was “very close” to applying for an emergency use approval (EUA) for its COVID-19 vaccine, according to a report. This, after the company began collecting safety data to submit to regulators in … Read more
Sputnik V COVID-19 vaccine was “more than 90%” effective, according to Russia’s health ministry. A representative of Russia’s health ministry on Monday said that Sputnik V COVID-19 vaccine was “more than 90%” effective. This, after Pfizer and BioNTech announced that a jointly-developed COVID-19 vaccine was “90% effective” in its ongoing Phase 3 trials. In a … Read more
WHO Director-General hailed the COVID-19 vaccine news from Pfizer and BioNTech as “encouraging”. World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus hailed the COVID-19 vaccine news from Pfizer and BioNTech as “encouraging“. This, after Pfizer and BioNTech announced that a jointly-developed coronavirus vaccine was “90% effective” in ongoing Phase 3 trials. WHO Director-General Tedros Adhanom … Read more
COVID-19 vaccine was “90% effective” in Phase 3 trial, according to Pfizer and BioNTech. Pfizer and BioNTech on Monday announced that a jointly-developed COVID-19 vaccine was “90% effective” in ongoing Phase 3 trials. This, as the joint statement from Pfizer and BioNTech was released on Pfizer’s website as soaring COVID-19 cases across the world had … Read more
